Zhongmin Wang

Founder at AKESO, INC.

Net worth: 369 M $ as of 30/06/2025

56 year

94 connections

Consumer Services

Health Technology

Commercial Services

Profile

Zhongmin Wang is the founder of Akeso, Inc. since 2012, serving as Executive Director & Senior Vice President.
Former job includes Senior Director at Crown Bioscience, Inc. Education history includes a graduate degree from Northeastern University, a doctorate from Baylor College of Medicine conferred in 1998, and an undergraduate degree from the University of Science & Technology of China conferred in 1991.

Known holdings in public companies

Company	Date	Number of shares	Valuation	Valuation date
AKESO, INC. 3.51%	24/05/2025	3,14,92,881 ( 3.51% )	369 M $	30/06/2025

Latest news about Zhongmin Wang

Akeso : FORM OF PROXY FOR THE ANNUAL GENERAL MEETING TO BE HELD ON MONDAY, JUNE 28, 2021	13/21/13	PU
Akeso : VOLUNTARY ANNOUNCEMENT - INCLUSION IN THE MSCI CHINA INDEX	13/21/13	PU
Akeso : VOLUNTARY ANNOUNCEMENT - INITIATION OF VARIOUS CLINICAL TRIALS OF PD-1/VEGF BI-SPECIFIC ANTIBODY (AK112)	12/21/12	PU
Akeso : VOLUNTARY ANNOUNCEMENT - CADONILIMAB (PD-1/CTLA-4 BI-SPECIFIC ANTIBODY) OBTAINED APPROVAL TO INITIATE GLOBAL PHASE III CLINICAL TRIAL FOR FIRST-LINE TREATMENT OF ADVANCED CERVICAL CANCER	28/21/28	PU
Akeso : VOLUNTARY ANNOUNCEMENT - PENPULIMAB (PD-1) OBTAINED BREAKTHROUGH THERAPY DESIGNATION FROM FDA FOR THIRD-LINE TREATMENT OF METASTATIC NASOPHARYNGEAL CARCINOMA	30/21/30	PU

Zhongmin Wang active positions

Companies	Position	Start
AKESO, INC.	Founder	19/03/2012

All active positions of Zhongmin Wang

Former positions of Zhongmin Wang

Companies	Position	End
Crown Bioscience, Inc. Crown Bioscience, Inc. Miscellaneous Commercial ServicesCommercial Services Crown Bioscience, Inc. provides biomedical outsourcing solutions. It provides syngeneic and xenograft tumor models and custom model development and drug testing. The firm produces antibodies for therapeutic, diagnostic and theranostic applications. It also offers preclinical and drug development for anti-cancers therapeutics. The company was founded by Dr. Yiyou Chen, Dr. Yue Alexander Wu, Dr. William Pan and Dr. Faming Zhang in 2006 and is headquartered in Santa Clara, CA.	Corporate Officer/Principal	-

See the detail of Zhongmin Wang's experience

Training of Zhongmin Wang

University of Science & Technology of China	Undergraduate Degree
Northeastern University	Graduate Degree
Baylor College of Medicine	Doctorate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Zhongmin Wang's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies	1
AKESO, INC.	Health Technology

Private companies	1
Crown Bioscience, Inc. Crown Bioscience, Inc. Miscellaneous Commercial ServicesCommercial Services Crown Bioscience, Inc. provides biomedical outsourcing solutions. It provides syngeneic and xenograft tumor models and custom model development and drug testing. The firm produces antibodies for therapeutic, diagnostic and theranostic applications. It also offers preclinical and drug development for anti-cancers therapeutics. The company was founded by Dr. Yiyou Chen, Dr. Yue Alexander Wu, Dr. William Pan and Dr. Faming Zhang in 2006 and is headquartered in Santa Clara, CA.	Commercial Services

Private companies

Commercial Services

See company connections